The TENOFOVIR DISOPROXIL FUMARATE market is experiencing significant changes, fueled by changing treatment patterns for HIV and Hepatitis B and the rising demand in low- and middle-income nations. Furthermore, the rising prevalence of HIV, along with improved access to antiretroviral thera